Kyorin Pharmaceutical Co (TSE:4569) Market Cap : 円98,525 Mil (As of Jun. 03, 2024)

View and export this data going back to 2001. Start your Free Trial

What is Kyorin Pharmaceutical Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Kyorin Pharmaceutical Co's share price for the quarter that ended in Dec. 2023 was 円1780. Kyorin Pharmaceutical Co's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 57 Mil. Therefore, Kyorin Pharmaceutical Co's market cap for the quarter that ended in Dec. 2023 was 円102,001 Mil.

Kyorin Pharmaceutical Co's quarterly market cap increased from Jun. 2023 (円100,339 Mil) to Sep. 2023 (円104,923 Mil) but then declined from Sep. 2023 (円104,923 Mil) to Dec. 2023 (円102,001 Mil).

Kyorin Pharmaceutical Co's annual market cap declined from Mar. 2022 (円101,825 Mil) to Mar. 2023 (円97,646 Mil) but then increased from Mar. 2023 (円97,646 Mil) to Mar. 2024 (円104,155 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Kyorin Pharmaceutical Co's Enterprise Value for Today is 円105,486 Mil.

Kyorin Pharmaceutical Co Market Cap Historical Data

The historical data trend for Kyorin Pharmaceutical Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kyorin Pharmaceutical Co Market Cap Chart

Kyorin Pharmaceutical Co Annual Data

Trend

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Market Cap

Get a 7-Day Free Trial

125,916.61

110,479.99

101,825.48

97,645.85

104,154.67

Kyorin Pharmaceutical Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Market Cap	Get a 7-Day Free Trial															97,645.85	100,339.13	104,923.44	102,000.94	104,154.67

Competitive Comparison of Kyorin Pharmaceutical Co's Market Cap

For the Drug Manufacturers - Specialty & Generic subindustry, Kyorin Pharmaceutical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kyorin Pharmaceutical Co's Market Cap Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Kyorin Pharmaceutical Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Kyorin Pharmaceutical Co's Market Cap falls into.

Kyorin Pharmaceutical Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Kyorin Pharmaceutical Co's Market Cap for the fiscal year that ended in Mar. 2024 is calculated as

Market Cap (A: Mar. 2024 )	=	Share Price (A: Mar. 2024 )	*	Shares Outstanding (EOP) (A: Mar. 2024 )
	=	円1813	*	57.4488
	=	円104,155

Kyorin Pharmaceutical Co's Market Cap for the quarter that ended in Dec. 2023 is calculated as

Market Cap (Q: Dec. 2023 )	=	Share Price (Q: Dec. 2023 )	*	Shares Outstanding (EOP) (Q: Dec. 2023 )
	=	円1780	*	57.3039
	=	円102,001

Kyorin Pharmaceutical Co (TSE:4569) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.

Kyorin Pharmaceutical Co Market Cap Related Terms

Thank you for viewing the detailed overview of Kyorin Pharmaceutical Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.

Kyorin Pharmaceutical Co (TSE:4569) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Kyorin Pharmaceutical Co Ltd (TSE:4569) » Definitions » Market Cap

Comparable Companies

Traded in Other Exchanges

N/A

Address

6, Kanda Surugadai 4-chome, Chiyoda-ku, Tokyo, JPN, 101-8311

Website

https://www.kyorin-pharm.co.jp

Kyorin Pharmaceutical Co Ltd is engaged in manufacturing and sale of pharmaceutical products. The company manages its business in two reportable segments namely Pharmaceutical Business and the Consumer Healthcare (Skincare) Business. The Pharmaceutical business focuses on producing and selling ethical drugs, generic drugs and over-the-counter drugs. The Consumer Healthcare (Skincare) Business mainly sells and purchases skincare products. The company's products include Kipres, for treating bronchial asthma and allergic rhinitis; Mucodyne, a mucoregulant; Pentasa, for treating ulcerative colitis and Crohn's disease; and Uritos, for treating overactive bladder. Majority of the company's revenue comes from domestic sales.

Kyorin Pharmaceutical Co (TSE:4569) Headlines

No Headlines